| scholarly article | Q13442814 |
| P50 | author | József Tőzsér | Q42601696 |
| P2093 | author name string | József Tözsér | |
| P2860 | cites work | The discovery of endogenous retroviruses | Q21245201 |
| Retroviral proteases | Q24791668 | ||
| Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes | Q27638967 | ||
| Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus | Q27729877 | ||
| On the size of the active site in proteases. I. Papain | Q27860826 | ||
| Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2 | Q28331185 | ||
| Effect of substrate residues on the P2' preference of retroviral proteinases | Q28372993 | ||
| Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus | Q28468752 | ||
| Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). | Q30698124 | ||
| Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases | Q30708352 | ||
| Molecular characterization of proteolytic processing of the Gag proteins of human spumaretrovirus | Q30794942 | ||
| Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease. | Q30860360 | ||
| Combating susceptibility to drug resistance: lessons from HIV-1 protease. | Q52560699 | ||
| Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid | Q54693321 | ||
| Crystal structure of a retroviral protease proves relationship to aspartic protease family | Q58039010 | ||
| Proteolytic Processing of Particle-Associated Retroviral Polyproteins by Homologous and Heterologous Viral Proteinases | Q62396126 | ||
| Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity | Q73456257 | ||
| Cleavage of vimentin by different retroviral proteases | Q73876603 | ||
| Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers | Q77188559 | ||
| Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis | Q44278229 | ||
| Cloning, bacterial expression, and characterization of the Mason-Pfizer monkey virus proteinase | Q44283494 | ||
| Kinetic and modeling studies of S3-S3' subsites of HIV proteinases | Q44403208 | ||
| Human immunodeficiency virus type 1 capsid protein is a substrate of the retroviral proteinase while integrase is resistant toward proteolysis | Q44466913 | ||
| Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease | Q44854785 | ||
| Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites | Q44968894 | ||
| Studies on the role of the S4 substrate binding site of HIV proteinases | Q45058440 | ||
| Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus proteases | Q45403148 | ||
| Specificity studies on retroviral proteinase from myeloblastosis-associated virus | Q45640881 | ||
| Specific in vitro cleavage of Mason-Pfizer monkey virus capsid protein: evidence for a potential role of retroviral protease in early stages of infection. | Q45723200 | ||
| Cloning of the bovine leukemia virus proteinase in Escherichia coli and comparison of its specificity to that of human T-cell leukemia virus proteinase | Q45743802 | ||
| Moloney murine leukemia virus protease expressed in bacteria is enzymatically active | Q45756806 | ||
| Expression, characterisation and mutagenesis of the aspartic proteinase from equine infectious anaemia virus | Q45766402 | ||
| Comparative studies on the substrate specificity of avian myeloblastosis virus proteinase and lentiviral proteinases | Q45770708 | ||
| Molecular model of equine infectious anemia virus proteinase and kinetic measurements for peptide substrates with single amino acid substitutions | Q45775518 | ||
| Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates | Q45775520 | ||
| Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme. | Q45775980 | ||
| Analysis of cross reactivity of retrovirus proteases using a vaccinia virus-T7 RNA polymerase-based expression system | Q45788800 | ||
| Chemical synthesis of a biotinylated derivative of the simian immunodeficiency virus protease. Purification by avidin affinity chromatography and autocatalytic activation | Q45866305 | ||
| Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates | Q45879616 | ||
| Expression of the protease gene of equine infectious anemia virus in Escherichia coli: Formation of the mature processed enzyme and specific cleavage of the gag precursor | Q45879807 | ||
| Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease | Q46343686 | ||
| A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base | Q31161899 | ||
| HIV-1 protease: maturation, enzyme specificity, and drug resistance. | Q34050688 | ||
| Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins | Q34098983 | ||
| Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs. | Q34334101 | ||
| Infection with HIV-2. | Q34509290 | ||
| Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use. | Q34757009 | ||
| Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases | Q35020110 | ||
| Proteolytic events of HIV-1 replication as targets for therapeutic intervention. | Q35181522 | ||
| Proteolytic processing of foamy virus Gag and Pol proteins | Q35196129 | ||
| HIV-1 Protease: Structural Perspectives on Drug Resistance | Q35259855 | ||
| Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). | Q36877852 | ||
| HIV-1 drug resistance mutations: an updated framework for the second decade of HAART | Q36900010 | ||
| Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site. | Q36933950 | ||
| HIV-1 protease inhibitors: effects on HIV-2 replication and resistance | Q37022422 | ||
| Simian foamy virus infection in humans: prevalence and management | Q37503347 | ||
| Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon | Q37680247 | ||
| Retroviral proteinases | Q37950642 | ||
| Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein | Q38290008 | ||
| Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus | Q38292179 | ||
| Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease | Q38307096 | ||
| Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases | Q38309110 | ||
| Mutations that alter the activity of the Rous sarcoma virus protease | Q38328817 | ||
| Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase | Q39448362 | ||
| Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus | Q39752728 | ||
| The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. | Q40042979 | ||
| Subsite preferences of retroviral proteinases | Q40591356 | ||
| Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates | Q40591362 | ||
| An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase | Q41519480 | ||
| Purification and characterization of the mouse mammary tumor virus protease expressed in Escherichia coli | Q41787182 | ||
| Kinetic characterization and cross-resistance patterns of HIV-1 protease mutants selected under drug pressure | Q42277211 | ||
| HIV protease cleaves poly(A)-binding protein. | Q42533713 | ||
| Recombinant HIV2 protease processes HIV1 Pr53gag and analogous junction peptides in vitro. | Q42633395 | ||
| Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites | Q42702065 | ||
| Role of the foamy virus Pol cleavage site in viral replication | Q42737934 | ||
| Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease | Q42803509 | ||
| Comparison of the substrate-binding pockets of the Rous sarcoma virus and human immunodeficiency virus type 1 proteases. | Q43599066 | ||
| Expression and characterization of human foamy virus proteinase | Q44169601 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 147-165 | |
| P577 | publication date | 2010-01-14 | |
| P1433 | published in | Viruses | Q7935305 |
| P1476 | title | Comparative studies on retroviral proteases: substrate specificity | |
| P478 | volume | 2 |
| Q92057075 | An n→π* Interaction in the Bound Substrate of Aspartic Proteases Replicates the Oxyanion Hole |
| Q92517990 | Biochemical characterization of Ty1 retrotransposon protease |
| Q38723523 | Construction of a molecular clone of ovine enzootic nasal tumor virus |
| Q39150767 | Development of [Ile⁴⁰]HTLV-I protease inhibition assay using novel fluorogenic and chromogenic substrate |
| Q89805637 | Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases |
| Q44005820 | Epidemiology and genetic diversity of bovine leukemia virus. |
| Q35259855 | HIV-1 Protease: Structural Perspectives on Drug Resistance |
| Q90138276 | Improved GaLV-TR Glycoproteins to Pseudotype Lentiviral Vectors: Impact of Viral Protease Activity in the Production of LV Pseudotypes |
| Q42288628 | Ion specific effects of alkali cations on the catalytic activity of HIV-1 protease |
| Q41490002 | Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease |
| Q59359799 | Overexpression, Purification and Functional Characterisation of Wild-Type HIV-1 Subtype C Protease and Two Variants Using a Thioredoxin and His-Tag Protein Fusion System |
| Q47576680 | Proteases and protease inhibitors in infectious diseases |
| Q90015434 | Protein Sequence Editing of SKN-1A/Nrf1 by Peptide:N-Glycanase Controls Proteasome Gene Expression |
| Q38223683 | Research applications of proteolytic enzymes in molecular biology. |
| Q38632850 | Special issue: retroviral enzymes. |
| Q40847794 | Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors. |
| Q37027897 | The N-end rule and retroviral infection: no effect on integrase |
Search more.